AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Starfighters Space today, you have to believe the F-104 fleet and “Wind Tunnel in the Sky” concept can evolve into a real commercial test infrastructure for defense, hypersonic and microgravity customers, and that partnerships with GE Aerospace, Mu-g Technologies and Blackstar Orbital eventually translate into paying contracts rather than just technical milestones. The delayed 10-Q filing on 14 August 2026 complicates that story at the margin, because it lands on top of a fresh auditor change, prior going concern language, zero revenue and a share price that has already fallen more than 50% year to date. In the near term, the key catalysts remain contract wins, STARLAUNCH 1 CDR progress and effective use of the recent US$17,500,000 raise, but the new filing delay heightens the risk that liquidity and governance stay front and center.
However, one near-term risk around transparency and funding is particularly important for investors to understand. The analysis detailed in our Starfighters Space valuation report hints at an inflated share price compared to its estimated value.Two Simply Wall St Community fair value views span from cents per share to several US dollars, underlining how far apart expectations currently sit. Set that against the filing delay and going concern history, and it is clear you are weighing execution risk and disclosure quality as much as the flight test technology itself. This is exactly where comparing different viewpoints can sharpen your own assessment of Starfighters’ potential path.
Explore 2 other fair value estimates on Starfighters Space - why the stock might be worth as much as 18% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Our top stock finds are flying under the radar-for now. Get in early:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com